NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...
Marie Claire on MSN
2026 is the year of the chin
The desire for a well-defined chin and a complementing jawline is nothing new. For years, implants were the go-to for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback